Switchback Systems is accelerating the Synthetic Biology Revolution by placing tools directly in the hands of scientists. Through a simplified approach, we’ve developed a unique, highly scalable DNA synthesis platform, with a focus on dramatic minimization of time, cost, and waste.

This revolutionary system will catalyze growth and progress in every imaginable industry, from pharmaceuticals to agriculture to plastics, and beyond.

With our proprietary technology, Switchback Systems aims to revolutionize the DNA synthesis market by providing customers with a deployable benchtop DNA synthesis platform.

The plug-and-play Switchback platform is self-contained, with both onboard oligonucleotide synthesis and gene assembly capabilities. This streamlined, unique approach eclipses the current, outdated service model and enables the synthetic biology revolution directly in scientists’ hands to build a better and more sustainable future.

Switchback Systems has the honor to be the first portfolio company to come out of the General Inception Venture Studio. It is now funded and supported by additional venture capital firms, including OMX Ventures, Vertical Venture Partners and Ahren Innovation Capital.

If you would like to be an investment partner, please contact us for more information.